It was widely reported this morning that Pfizer Pharmaceuticals is finding positive results in the Phase Two trials of a vaccine for Covid-19 protection. The federal effort to secure an effective vaccine may not play out as promised, however. The nearly $2 billion dollars it placed on the table sounds formidable but may in fact Read More